StockVS

Archimedes Tech SPAC Partners II Co. (ATII) 股票分析

金融服务

Archimedes Tech SPAC Partners II Co.

$11.33

$-0.05 (-0.44%)

最后更新: 2026年5月26日

价格走势

分析

公司概述

Archimedes Tech SPAC Partners II Co. operates as a shell entity within the financial services sector, specifically categorized under the industry of shell companies, indicating its transitional status prior to a definitive business combination. The company does not possess significant operational assets or revenue-generating activities currently, as it intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses in the technology industry. This strategic positioning suggests that the firm is in the preparatory phase of a merger, aiming to bring technology-focused operations to public markets through a Special Purpose Acquisition Company (SPAC) structure. The current market capitalization stands at $308.03 million, while annual revenue figures are not applicable due to the lack of significant operations, and the number of employees is listed as N/A. These valuation metrics reflect the speculative nature of the entity, where the market cap represents the value assigned to the potential future business rather than existing operational performance or earnings generation capabilities.

财务健康

The financial statements for Archimedes Tech SPAC Partners II Co. present a unique profile typical of pre-merger SPACs, with reported revenue for the trailing twelve months (TTM) listed as N/A due to the absence of significant business operations. Despite the lack of revenue, the company reported a net income of $7.99 million for the TTM period, a figure that creates a distinct divergence from traditional cost structures where net income usually trails revenue; in this context, the income likely stems from interest income on the trust account or other non-operational sources rather than core business profitability. The company's EBITDA is not available for reporting, which prevents a standard assessment of operating cash generation before interest, taxes, depreciation, and amortization. Free cash flow is also listed as N/A, indicating that the company has not generated operational cash flows sufficient to measure flexibility through this metric, relying instead on its initial proceeds. Regarding profitability margins, the gross margin, operating margin, and profit margin are all recorded at 0.0%, which is consistent with a company that has not yet commenced significant commercial activities to generate these specific financial line items. The balance sheet shows a cash balance of $1.36 million against zero reported debt, highlighting a highly conservative liquidity posture devoid of leverage obligations. Although the debt-to-equity ratio is not applicable given the N/A debt figure, the presence of cash without debt suggests the entity is not leveraged. The current ratio is reported at 10.72, a figure that indicates an extremely strong short-term liquidity position, suggesting the company holds significantly more current assets than current liabilities relative to its specific accounting treatment for a shell entity. Return on Equity is N/A, while Return on Assets stands at -0.4%, a negative metric that reveals how the company's asset base is currently contributing to its financial results in the absence of traditional operating income.

估值评估

The valuation of Archimedes Tech SPAC Partners II Co. is characterized by a trailing P/E ratio of 34.70, while the forward P/E is listed as N/A, implying that analysts or the market lacks sufficient projected earnings data to calculate a forward multiple, which is common for shell companies awaiting a target. The price-to-book ratio is reported as -45.86, a negative figure that indicates the market price is trading below the book value or reflects accounting adjustments specific to the trust structure, rather than a traditional market premium over tangible book value. Alternative valuation metrics such as the price-to-sales ratio and EV/EBITDA are both listed as N/A, reflecting the inability to apply these standard multiples to a company without significant revenue or earnings. The stock's recent trading range is bounded by a 52-week high of $10.70 and a 52-week low of $9.96, providing a reference band for market participants to gauge recent volatility and price discovery within the SPAC sector. Although the beta value is listed as N/A, preventing a direct calculation of price volatility relative to the broader market, the narrow 52-week trading range of approximately $0.74 suggests limited price movement over the past year. The absence of a forward P/E and the negative price-to-book ratio collectively underscore that standard valuation frameworks used for mature operating companies are not directly applicable to this transitional financial vehicle.

Growth & Income

The revenue growth year-over-year and earnings growth year-over-year are both listed as N/A, as the company does not yet have a track record of growth from a prior period of significant operations. Consequently, it is not possible to compare the growth trajectory of earnings against revenue growth, as both metrics are currently non-existent in a traditional sense. As a non-dividend payer, the company does not distribute a dividend yield, which is listed as N/A, nor does it maintain a payout ratio, recorded as 0.0%. This absence of dividend payments aligns with the company's strategy of retaining capital and reinvesting earnings—likely held in trust accounts—into the pursuit of a business combination rather than distributing income to shareholders. The overall growth and income profile is defined by a complete lack of historical growth data and a zero payout policy, focusing entirely on the capital preservation required to facilitate a future merger with a technology industry target.

同行比较

Archimedes Tech SPAC Partners II Co. (ATII) 在壳公司行业运营。以下是其与市值最接近的同行的比较:

公司 代码 市值 市盈率
Archimedes Tech SPAC Partners II Co. ATII $335.25M 37.8
Twenty One Capital, Inc. XXI $2.49B N/A
Churchill Capital Corp X CCCX $711.00M N/A
Drugs Made In America Acquisition II Corp. DMII $641.46M 77.5

壳公司行业平均市盈率为82.8倍。Archimedes Tech SPAC Partners II Co.的市盈率为37.8。

本分析由AI生成,仅供参考,不构成投资建议。数据可能存在延迟或不准确。在做出投资决策之前,请务必进行自己的研究并咨询合格的财务顾问。

关于Archimedes Tech SPAC Partners II Co.

Archimedes Tech SPAC Partners II Co. does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses in the technology industry. Archimedes Tech SPAC Partners II Co. was incorporated in 2024 and is based in Claymont, Delaware.

公司简介以英文显示。

访问官网 →

关键指标

市值
$335.25M
市盈率
37.77
52周最高
$11.40
52周最低
$10.09
平均成交量
213.24K

数据由Yahoo Finance通过yfinance提供。每日更新。

公司信息

交易所
NASDAQ
国家
United States